ketoconazole has been researched along with Nutritional Disorders in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haug, C | 1 |
Müller, F | 1 |
Aukrust, P | 1 |
Frøland, SS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Vitamin D Status and T Cell Phenotype in HIV-infected Youth Supplemented With Cholecalciferol: a Randomized Clinical Trial.[NCT01656070] | Phase 2 | 50 participants (Actual) | Interventional | 2011-04-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for ketoconazole and Nutritional Disorders
Article | Year |
---|---|
Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival.
Topics: Acquired Immunodeficiency Syndrome; Biopterins; Calcitriol; CD4-Positive T-Lymphocytes; Follow-Up St | 1994 |